A detailed history of Sloy Dahl & Holst, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Sloy Dahl & Holst, LLC holds 5,414 shares of JNJ stock, worth $873,603. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,414
Previous 5,411 0.06%
Holding current value
$873,603
Previous $855,000 7.49%
% of portfolio
0.17%
Previous 0.2%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$144.38 - $157.78 $433 - $473
3 Added 0.06%
5,414 $791,000
Q1 2024

Apr 18, 2024

BUY
$155.22 - $162.74 $39,581 - $41,498
255 Added 4.95%
5,411 $855,000
Q4 2023

Jan 30, 2024

BUY
$145.6 - $158.88 $52,416 - $57,196
360 Added 7.51%
5,156 $808,000
Q3 2023

Nov 02, 2023

SELL
$155.75 - $174.48 $77,252 - $86,542
-496 Reduced 9.37%
4,796 $746,000
Q2 2023

Jul 19, 2023

SELL
$154.35 - $166.11 $48,157 - $51,826
-312 Reduced 5.57%
5,292 $875,000
Q4 2022

Jan 30, 2023

SELL
$160.2 - $179.79 $101,406 - $113,807
-633 Reduced 10.15%
5,604 $989,000
Q3 2022

Oct 19, 2022

SELL
$161.33 - $179.52 $1,451 - $1,615
-9 Reduced 0.14%
6,237 $1.02 Million
Q2 2022

Aug 02, 2022

BUY
$168.19 - $186.01 $168 - $186
1 Added 0.02%
6,246 $1.11 Million
Q1 2022

May 10, 2022

BUY
$158.14 - $179.59 $68,949 - $78,301
436 Added 7.51%
6,245 $1.11 Million
Q3 2021

Nov 03, 2021

BUY
$161.5 - $179.47 $51,195 - $56,891
317 Added 5.77%
5,809 $938,000
Q2 2021

Aug 11, 2021

SELL
$159.48 - $171.07 $41,783 - $44,820
-262 Reduced 4.55%
5,492 $904,000
Q1 2021

May 12, 2021

BUY
$153.07 - $170.48 $122,302 - $136,213
799 Added 16.13%
5,754 $946,000
Q4 2020

Feb 08, 2021

BUY
$137.11 - $157.38 $50,867 - $58,387
371 Added 8.09%
4,955 $726,000
Q1 2020

May 12, 2020

SELL
$111.14 - $153.99 $41,232 - $57,130
-371 Reduced 7.49%
4,584 $601,000
Q4 2019

Jan 21, 2020

BUY
$127.5 - $146.44 $631,762 - $725,610
4,955 New
4,955 $722,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $422B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sloy Dahl & Holst, LLC Portfolio

Follow Sloy Dahl & Holst, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sloy Dahl & Holst, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sloy Dahl & Holst, LLC with notifications on news.